Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

BusinesswireNov 22 07:00 ET

FDA Approves U.S. Pediatric Indication Extension for Palforzia Oral Immunotherapy for the Treatment of Peanut Allergy

BusinesswireJul 30 06:09 ET

Allergy Partners Announces Collaboration With Aimmune Therapeutics to Provide PALFORZIA® [Peanut (Arachis Hypogaea) Allergen Powder-dnfp] Directly to Patients

BusinesswireOct 13, 2022 17:20 ET

Global Food Allergy Market Report to 2032 - Featuring Aimmune Therapeutics, Novartis Pharmaceuticals and DBV Technologies Among Others - ResearchAndMarkets.com

BusinesswireJul 6, 2022 10:51 ET

Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection

BusinesswireNov 10, 2021 02:10 ET

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

GlobeNewswireNov 3, 2021 16:28 ET